Knock-off versions of Eli Lilly's retatrutide, hailed as a potential 'new Ozempic', are being sold directly to US consumers via Chinese websites despite being years away from regulatory approval.Hundreds of merchants are offering the new drug to buyers in the US via websites such as Made-in-China.com and GorillaHealing.com, . Some of the sites, including ones that appear to be based in the U.S., have marketed their products via posts on, LinkedIn and , according to the publication.
Load More
Load More